Drugs / human lactoferrin peptide 1-11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00509847 | Feb → Jul 2009 | staphylococcal infection | AM-Pharma | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human lactoferrin peptide 1-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00509847 ↗ |
| Modality | Peptide | “human lactoferrin 1-11 peptide” NCT00509847 ↗ |
| Route | Intravenous | “administered intravenously” NCT00509847 ↗ |